Jump to main content

About Gattex

Actor
portrayal

GATTEX® is a prescription medicine used in adults and children 1 year of age and older with short bowel syndrome (SBS) who are dependent on parenteral support (PS)

GATTEX works like a natural GLP-2.

In a study of adults, GATTEX was proven to help the remaining intestine absorb more fluid.*

Tick

Increased the surface area of the villi in the intestines

The image above is for illustrative purpose only.

Tick

Increased absorption of fluid by the intestines by ~750 to 1000 mL/day

The ability of GATTEX to improve the amount of fluid absorbed by the intestines was studied in 17 adults with SBS. Participants in the study received GATTEX for 21 days. All the participants in this study knew they were taking GATTEX. They each took daily doses of either 0.03, 0.10, or 0.15 mg/kg by injection (0.6 to 3 times the recommended dose). The injections were administered under the skin in the stomach area (abdomen). All of the doses studied, except for the 0.03 mg/kg once-daily dose, resulted in enhanced absorption of fluid by the intestines—approximately 750 to 1000 mL per day—and increased the surface area of the intestines.

The ability of GATTEX to improve intestinal absorption in children has not been investigated.

Gattex is the first and only medicine that works like the glp-2 the body normally makes on its own

Common Side Effects of GATTEX

In clinical studies of adults, the most common (≥10%) side effects were:

Stomach area (abdomen) pain or swelling

Vomiting

Nausea

Swelling of the hands or feet

Cold or flu symptoms

Allergic reactions

Skin reaction where the injection was given

The safety of GATTEX has been studied in 41 children with SBS across 2 clinical studies*

The side effects seen in children and adolescents (aged 1 to 17 years) were similar to those seen in adults. Be sure to talk to your or your child’s doctor about any side effects that are bothersome or that do not go away.

This includes pediatric patients from an additional 3-month study that was conducted with GATTEX.

Gattex has been approved for use in children since 2019 And has been prescribed for adults with sbs since 2012

Keep track of the treatment journey

Things to keep in mind during your or your loved one's journey with GATTEX

tracking your experiences

Track your or your child’s experiences and keep detailed notes that can be used in conversations with the doctor.

talking to your doctor

Check in with the doctor and talk openly about what you or your child are experiencing.

Everyone with sbs is unique. Experiences with gattex will be too.

Considering GATTEX?

Download our helpful Conversation Guide or see what goes into getting started

Getting started

Stay informed and connected

Sign up to receive ongoing updates and communications about upcoming events, treatment information, education, resources, and market research opportunities.

*First name is required
*Last name is required
*Email address is required
*Zip Code is required

Do you or someone you care for have SBS?*

Select one
*Please select an option

Age of Person Experiencing Bowel Problems*

HAVE YOU CONSIDERED MEDICATION/TREATMENT FOR SHORT BOWEL SYNDROME?*


*Please select an option

All fields marked with * are required.

Please see our online privacy notice for information about our practices regarding collection, use, and disclosure of information that you may provide us.